DIA 2025 Global Annual Meeting

Component Type: Workshop
Level: Intermediate

The healthcare industry is rapidly transforming with AI, necessitating new regulations for its use in drug development. This session proposes collaboration between pharma, biotech, and regulators to co-create a framework ensuring AI-driven innovation

Learning Objectives

Understand the key challenges and regulatory considerations in scaling AI-driven solutions for drug development in healthcare. Explore strategies for effective collaboration between pharma, biotech, and regulatory bodies to create a unified AI framework. Identify actionable steps to ensure AI integration in healthcare is safe, transparent, and compliant with evolving regulations.

Chair

Sridevi Nagarajan, PhD, MS, MSc